AR033261A1 - Antagonistas de nmda para el tratamiento de enfermedades adictivas - Google Patents

Antagonistas de nmda para el tratamiento de enfermedades adictivas

Info

Publication number
AR033261A1
AR033261A1 ARP020101479A ARP020101479A AR033261A1 AR 033261 A1 AR033261 A1 AR 033261A1 AR P020101479 A ARP020101479 A AR P020101479A AR P020101479 A ARP020101479 A AR P020101479A AR 033261 A1 AR033261 A1 AR 033261A1
Authority
AR
Argentina
Prior art keywords
treatment
nmda antagonists
addictive diseases
addictive
diseases
Prior art date
Application number
ARP020101479A
Other languages
English (en)
Inventor
Bartoszyk Gerd Dr
Seyfried Christoph Dr
Pruecher Helmut Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR033261A1 publication Critical patent/AR033261A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de antagonistas de NMDA para el tratamiento de enfermedades adictivas. En experimentos en animales se observo una clara reduccion del consumo de etanol en ratas alcoholicas por administracion de un compuesto de la formula (1).
ARP020101479A 2001-04-25 2002-04-24 Antagonistas de nmda para el tratamiento de enfermedades adictivas AR033261A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10120159A DE10120159A1 (de) 2001-04-25 2001-04-25 NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen

Publications (1)

Publication Number Publication Date
AR033261A1 true AR033261A1 (es) 2003-12-10

Family

ID=7682608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101479A AR033261A1 (es) 2001-04-25 2002-04-24 Antagonistas de nmda para el tratamiento de enfermedades adictivas

Country Status (3)

Country Link
AR (1) AR033261A1 (es)
DE (1) DE10120159A1 (es)
WO (1) WO2002085352A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005432B2 (en) 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
WO2006137465A1 (ja) * 2005-06-24 2006-12-28 Shionogi & Co., Ltd. 含窒素複素環誘導体
DE102007047737A1 (de) 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
DE102009049211A1 (de) 2009-10-13 2011-04-28 Merck Patent Gmbh Sulfoxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
DK0709384T3 (da) * 1994-10-31 1999-08-23 Merck Patent Gmbh Benzylpiperidinderivater med høj affinitet til aminosyrereceptorers bindingssteder
DE19643790A1 (de) * 1996-10-30 1998-05-07 Merck Patent Gmbh Benzoxazol-Derivat
JPH10287568A (ja) * 1997-04-14 1998-10-27 Grelan Pharmaceut Co Ltd アルコール依存症治療剤

Also Published As

Publication number Publication date
WO2002085352A1 (de) 2002-10-31
DE10120159A1 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
MY139475A (en) Process for the preparation of (1s)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid addition salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts
YU69902A (sh) Novi derivati piperazina
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
RS50720B (sr) 3,11 b-cis-dihidrotetrabenazin za lečenje proliferativne bolesti ili inflamacije
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
SE0201544D0 (sv) Novel compounds and thier use
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
RS53211B (en) PYRIDO [2,3-d] PYRIMIDINE DERIVATIVES, THEIR PRODUCTION, THEIR USE IN THERAPY
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
DE60114640D1 (en) Antithrombosemittel
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
AR033261A1 (es) Antagonistas de nmda para el tratamiento de enfermedades adictivas
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
MXPA02012400A (es) Heterociclos hetaril-substituidos.
HK1046143A1 (en) Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa

Legal Events

Date Code Title Description
FA Abandonment or withdrawal